Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

Medicine, Oncology, Pathology +15

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

Public Health, Biostatistics, Experimental Design +10

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

Anas Younes, Nancy L. Bartlett, John P. Leonard et al. · New England Journal of Medicine · 2010 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Role of the histone deacetylase complex in acute promyelocytic leukaemia

Richard J. Lin, László Nagy, Satoshi Inoue et al. · Nature · 1998 · 1.1K citations

Life Sciences, Hematology, Molecular Biology +14

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

Neil A. Marshall, Linsey Christie, Laura Munro et al. · Blood · 2003 · 512 citations · Full text

Life Sciences, Immunology, Oncology +13